Make Informed Investment Decisions with Affordable Access to Experts

This project has been flagged by a community member as inappropriate due to reason below.*

Freedom of Information Act Request

Slingshot members are requesting the following information:

To see if we can get the specific DOJ requests to Pharma companies on drug pricing. These investigations have been confirmed in 10q filings.

Ticker(s): MRK, VRX, LLY
Why are users requesting this information?

The breadth of these investigations and the legal angle the government is taking are important to understand when evaluating the potential ramifications on the industry. The comments around drug pricing have dominated headlines, and more details and specifics are important to understanding what is going on. The government would not confirm the existence of these inquires to the WSJ, but will have to disclose something it under the FOIA requirements. Investors know the investigation exists because of SEC disclosure requirements. WSJ article: http://www.wsj.com/articles/lilly-merck-receive-inquiries-from-justice-dept-over-drug-pricing-144682...

Government Agency: DOJ

Specific Documents Requested: The correspondence between the DOJ and the drug manufacturers. Specifically the initial inquiries and any follow-up correspondence.

Do you want access to these documents?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.